Samumed Presents Safety Data Analysis of Lorecivivint for Knee Osteoarthritis at the 2019 ACR Annual Meeting

NEXT STORY
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
PREV STORY
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions

Approximately 98% of patients receiving highest dose achieved reductions in Lp(a) levels below the ...

author_avatar
NASDAQ Market News

Richard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery Consortium

author_avatar
NASDAQ Market News

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

author_avatar
NASDAQ Market News